| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.6 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |